Toripalimab combined with nab-paclitaxel/gemcitabine as first-line treatment for advanced pancreatic adenocarcinoma: Updated results of a phase Ib/II clinical study ...
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, today announced the close of a $21.5 million Series B financing.
Andrea Kasinski, Purdue Institute for Cancer Research (PICR) deputy director and professor of biological sciences in Purdue’s College of Science, has been awarded a competitive translational grant ...
Nearly 1 million Windows devices were targeted in recent months by a sophisticated “malvertising” campaign that surreptitiously stole login credentials, cryptocurrency, and other sensitive information ...
SAN FRANCISCO--(BUSINESS WIRE)--Spotlight Therapeutics, Inc. (“Spotlight”), a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, today ...
Carina Biotech Pty Ltd. has submitted an IND application to the FDA to conduct a first-in-human phase I/IIa trial of CNA-3103, its LGR5-targeted chimeric antigen receptor T-cell (CAR-T) therapy ...
CARLSBAD, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for ...
New Devices Offer Plethora of Communications Options, Capacitive Touch Interface, and Dual-Bank Flash for Software Updates Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback